Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![doepke_michel Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1350720698591936515.png) Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4855 followers
Created: 2025-07-16 05:20:12 UTC

#Akeso Announces First Patient Enrolled in the Phase III Trial AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer. $SMMT


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945352745789075532/c:line.svg)

**Related Topics**
[$9926hk](/topic/$9926hk)
[$smmt](/topic/$smmt)

[Post Link](https://x.com/doepke_michel/status/1945352745789075532)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

doepke_michel Avatar Michel Doepke @doepke_michel on x 4855 followers Created: 2025-07-16 05:20:12 UTC

#Akeso Announces First Patient Enrolled in the Phase III Trial AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer. $SMMT

XXXXX engagements

Engagements Line Chart

Related Topics $9926hk $smmt

Post Link

post/tweet::1945352745789075532
/post/tweet::1945352745789075532